Abstract
In 2021, the WHO published a plan to defeat meningitis worldwide. It is still a disease of great public health relevance, with high mortality and morbidity. Vaccines produced against the main bacteria that cause meningitis are effective, but induce a serotype/serogroup-dependent response, and as a result, can promote the replacement of circulating serotypes/serogroups in the population. T…